ADVFN US – Market Content Editor
-
S&P 500 Could Drop 11% if Trade War Escalates, Morgan Stanley’s Wilson Warns
The strong equity rally that started in April may face a deeper correction as trade tensions between the U.S. and China intensify, according to Michael Wilson of Morgan Stanley. Technical signals suggest the S&P 500 could fall around 11% if there’s no easing of tensions in the coming weeks. Wilson explained that the setup for…
-
Silver Prices Break Records as Gold Rally and Supply Shortage Fuel Buying Frenzy
Silver prices surged to new highs on Monday, climbing 5% in early trading as investors piled into precious metals amid a strong gold rally and mounting supply constraints in the physical market. In New York, silver futures reached $49.63 an ounce, while spot gold jumped 2.7% to $51.66, underscoring heightened demand for safe-haven assets in…
-
Five Market Themes to Watch in the Week Ahead
A renewed flare-up in U.S.-China trade tensions is set to dominate investor attention this week, even as U.S. futures pushed higher on Monday after President Donald Trump struck a less confrontational tone. Artificial intelligence is also likely to remain in the spotlight, with Oracle Corporation hosting a major event. Meanwhile, results from ASML Holding N.V.…
-
G20 Watchdog Issues Warning Over Fragile Markets Amid Soaring Asset Prices
The Financial Stability Board (FSB) has warned that the recent surge in global stock markets and asset values could make financial markets more prone to a sharp correction, as economic and geopolitical uncertainties continue to build. In an October 8 letter to G20 finance ministers, FSB Chair Andrew Bailey emphasized the importance of international cooperation…
-
U.S. Rare Earth Miners Rally as Trump Reignites Trade Tensions with China
Shares of U.S.-listed rare earth mining companies surged in premarket trading on Monday after President Donald Trump threatened to introduce steep new tariffs on Chinese imports in response to Beijing’s latest export restrictions on rare earth minerals. As of 10:00 a.m. GMT, Critical Metals Corp (NASDAQ:CRML) was up more than 20%, while USA Rare Earth…
-
Dow Jones, S&P, Nasdaq, Wall Street, Futures Jump as Trump Signals Softer Approach to China — Key Market Movers
U.S. stock futures climbed on Monday as President Donald Trump struck a less confrontational tone toward Beijing over the weekend, helping ease fears of an escalating trade conflict. While he recently threatened steep tariffs, Trump emphasized he was not trying to “hurt” China. Strong Chinese export data added to positive sentiment, while safe-haven flows lifted…
-
Dollar Drops as Trump Eases Tone on Trade Tensions with China
The U.S. dollar weakened on Monday as investors grew more optimistic that Washington might take a softer stance on trade following its latest escalation against Beijing. The greenback’s slide came after Friday’s heavy market selloff, while political shifts in France and Japan weighed on the euro and yen. The dollar index, which tracks the currency…
-
Oil Prices Recover from Five-Month Lows as Markets Look to US-China Talks
Crude oil prices moved higher on Monday, regaining some of the sharp losses from the previous session, as investors focused on the possibility of trade negotiations between the U.S. and China that could ease tensions between the world’s top two economies and energy consumers. Brent crude futures climbed 92 cents, or 1.47%, to $63.65 per…
-
Gold Prices Surge to Record Levels Near $4,100/oz Amid Trade Tensions
Gold prices soared to fresh all-time highs in Asian trading on Monday, nearing the $4,100-per-ounce mark as escalating trade frictions between the U.S. and China reignited demand for safe-haven assets. Spot gold climbed 1.3% to $4,070.29 per ounce by 02:53 ET (05:53 GMT) after reaching an intraday record of $4,078.05 earlier in the session. U.S.…
-
Trump Administration Reaches Pricing Agreement with AstraZeneca
U.S. President Donald Trump’s administration and AstraZeneca (NASDAQ:AZN) announced Friday that they have finalized a deal for the U.K.-based drugmaker to lower the cost of its medicines in the United States. This accord mirrors a similar pricing arrangement reached late last month with Pfizer (NYSE:PFE). As part of the deal, AstraZeneca will provide its drugs…